SignalPath
SignalPath is a Raleigh-based clinical research software company building a Clinical Trial Management System (CTMS) for clinical research sites and sponsors, now operating as Verily's Viewpoint Site CTMS within Alphabet's precision health platform.
- Company typePrivate
- Founded2014
- HeadquartersRaleigh, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What SignalPath does
SignalPath is a U.S.-based clinical research software company founded in 2014 and headquartered in Raleigh, North Carolina. The company designs and develops Clinical Trial Management System (CTMS) software intended to improve the operational ease, efficiency, and quality of clinical research at the site and sponsor level. Its core product is a site-focused CTMS that addresses the workflow complexity, data tracking, and quality control demands faced by clinical research organizations conducting trials.
The company's technology stack is built around a proprietary CTMS platform that has been integrated into Verily's broader Viewpoint solution suite — a multi-product offering covering clinical research acceleration, alongside Verily's other products (Pre, Lightpath, Sightline, and Verily Me). The platform positions itself as an enterprise solution for clinical research sites, with a sales-led go-to-market model evidenced by a "Request a demo" engagement flow on the product page. The underlying technology is described within the Viewpoint suite as part of an AI-native precision health platform, indicating architectural alignment with modern, data-driven clinical research workflows.
SignalPath's business model is enterprise B2B SaaS, monetizing through site-level CTMS licenses sold to clinical research organizations and sponsors. The company scaled to 51–100 employees and raised approximately $34.5M across five funding rounds between 2014 and 2019, culminating in a $18M Series 2 in October 2019. The company was subsequently acquired by Verily (an Alphabet subsidiary), where the SignalPath CTMS now operates as Viewpoint Site CTMS within Verily's portfolio. No standalone revenue, customer counts, or pricing details are publicly disclosed.
SignalPath firmographics
Firmographics- Name
- SignalPath
- Website
- https://signalpath.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SignalPath is a Raleigh-based clinical research software company building a Clinical Trial Management System (CTMS) for clinical research sites and sponsors, now operating as Verily's Viewpoint Site CTMS within Alphabet's precision health platform.
- Ownership category
- akta.pro rank
SignalPath industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Management Systems (CTMS) (HLACAOAD)
- akta.pro secondary industries
- Decentralized/Hybrid Trial Enablement (DCT) Platforms (HLACAOAL), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where SignalPath is headquartered
LocationHeadquarters
- HQ city
- Raleigh
- HQ country
- United States
- HQ region
- North America
Markets served
SignalPath business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Distribution channels1 record
Marketing channels1 record
SignalPath product offering
Product offeringCore offering
SignalPath designs and provides the next generation of software for the clinical research site and sponsor. Its flagship offering is a Clinical Trial Management System (CTMS) engineered to improve the ease, efficiency, and quality of clinical research operations for research sites and sponsor organizations.
Product overview
Verily offers a multi-product solution suite called Viewpoint designed to accelerate clinical research. Viewpoint Site CTMS is the core clinical trial management system offering within this suite, focused on improving operational aspects of site-level clinical trials. The Viewpoint suite is part of Verily's broader precision health platform alongside products like Pre (AI-native platform), Lightpath (personalized care), Sightline (population disease monitoring), and Verily Me (personal health companion).
Differentiator
Problem solved
Functional benefit
Products and services
- Viewpoint Site CTMS A Clinical Trial Management System (CTMS) designed to improve the ease, efficiency, and quality of clinical research operations for clinical research sites and sponsor organizations.
Companies that use SignalPath
Customer profileSegments1 record
Ideal customer profiles1 record
SignalPath technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
SignalPath partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
SignalPath competitors and assessment
Company assessmentDirect peers
- Veeva Systems: Veeva Systems is the dominant vendor of CTMS, eTMF, EDC and broader clinical operations software to pharma sponsors and CROs. It is the most direct competitor to SignalPath in the CTMS space and is the benchmark incumbent for clinical research SaaS.
- Castor: Castor provides a clinical trial platform spanning EDC, ePRO and CTMS-style functionality for sites and sponsors. It is an emerging direct peer targeting the same decentralized trial buyer with a modern cloud-native product.
- Bio-Optronics: Bio-Optronics builds the Clinical Conductor CTMS used by research sites and site management organizations. It is a direct competitor focused on the same research site buyer that SignalPath targets.
- Advarra: Advarra offers a CTMS (OnCore) alongside IRB and biosafety services targeting academic medical centers and research sites. It directly competes with SignalPath at the site level and is one of the most established site-focused CTMS products in the market.
- RealTime Software Solutions: RealTime delivers CTMS and eRegulatory solutions for research sites and SMOs. It competes head-on with SignalPath in the investigator-site CTMS category with comparable pricing and SaaS delivery models.
Broad incumbents
- Medidata (Dassault Systèmes): Medidata offers the Rave CTMS module alongside EDC, eCOA and the Patient Cloud decentralized trial suite. As a broad incumbent owned by Dassault Systèmes, it competes with SignalPath across both sponsor and site clinical operations software.
- IQVIA Technologies: IQVIA bundles CTMS, EDC, and the broader IQVIA Platform alongside its CRO services. As a broad incumbent CRO-plus-software player, it competes with SignalPath both directly (CTMS) and via integrated services-plus-tech bundles that can foreclose independent site software.
- Clario: Clario delivers eCOA, ECG, imaging and clinical trial software spanning site and sponsor buyers. It is a broad incumbent with overlapping DCT and clinical operations capabilities that compete with the Viewpoint Site CTMS positioning.
- Oracle Health Sciences (Clinical One): Oracle's Clinical One and former Phase Forward/Clintrial CTMS products address the same clinical trial management buyer as SignalPath. As a broad incumbent, Oracle bundles CTMS into a much wider life sciences platform, putting competitive pricing pressure on point solutions.
Emerging players
- Prism Clinical Research: Prism provides CTMS alternatives such as the eResearch suite for academic and community research sites. It is an emerging peer competing for the same site-level buyer with comparable functionality.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
SignalPath social profiles
Digital presenceSignalPath financial estimates
Financial estimateRevenue estimate
Valuation estimate
SignalPath leadership team
Management profileNumber of profiles
Profiles3 records
SignalPath funding detail
Funding detailFunding overview
Funding rounds5 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SignalPath M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SignalPath
What does SignalPath do?
SignalPath designs and provides the next generation of software for the clinical research site and sponsor. Its flagship offering is a Clinical Trial Management System (CTMS) engineered to improve the ease, efficiency, and quality of clinical research operations for research sites and sponsor organizations.
Is SignalPath a public or private company?
SignalPath is a private company. It is classified as venture growth investor backed and is currently operating.
When was SignalPath founded?
SignalPath was founded in 2014. It employs 51 to 100 people.
Where is SignalPath based?
SignalPath is headquartered in Raleigh, United States, in the North America region.
Who are SignalPath's main competitors?
Direct peers on record are Veeva Systems, Castor, Bio-Optronics, Advarra and RealTime Software Solutions. Broad incumbents are Medidata (Dassault Systèmes), IQVIA Technologies, Clario and Oracle Health Sciences (Clinical One). Prism Clinical Research is listed as an emerging player.
Does SignalPath have an API?
No public API is recorded for SignalPath.
What industry is SignalPath in?
SignalPath's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLACAOAD, Clinical Trial Management Systems (CTMS), with a secondary code of HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 541511 and its SIC code is 7372.